Hosted on MSN1mon
Bionano Genomics stock hits 52-week low at $4.9 amid sharp declinethe stock's RSI indicates oversold territory, while the company's high beta of 2.22 suggests significant volatility. This latest price level reflects a significant downturn for the genome analysis ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results